Scarica l'app Stockscreener
28.07
1.09%
-0.31
Precedente Chiudi:
$28.38
Aprire:
$28.5
Volume 24 ore:
177.77K
Relative Volume:
0.70
Capitalizzazione di mercato:
$1.93B
Reddito:
-
Utile/perdita netta:
$-48.26M
Rapporto P/E:
-35.54
EPS:
-0.7899
Flusso di cassa netto:
$-45.04M
1 W Prestazione:
+2.90%
1M Prestazione:
+4.43%
6M Prestazione:
+79.25%
1 anno Prestazione:
+95.47%
Intervallo 1D:
$27.86
$28.85
Intervallo di 1 settimana:
$26.32
$29.05
Portata 52W:
$11.32
$31.00
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
28.07 | 1.90B | 0 | -48.26M | -45.04M | -0.7899 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Iniziato | Needham | Buy |
| 2025-06-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Iniziato | Guggenheim | Buy |
| 2025-03-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-02-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-16 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Gh Research Plc Borsa (GHRS) Ultime notizie
GH Research PLC (GHRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GHRS|GH Research PLC|Price:27.830|Chg%:+0.550 - TradingKey
GHRS Initiated Coverage by Wells Fargo -- Price Target Announced at $44 - GuruFocus
GH Research PLC (GHRS) Institutional Confidence - TradingKey
GH Research PLC (GHRS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GH Research PLC (GHRS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GH Research PLC (GHRS) Valuation: PE, PB & Fair Value Analysis - TradingKey
GHRS|GH Research PLC|Price:27.280|Chg%:-0.350 - TradingKey
GH Research PLC (GHRS) Cash Flow - TradingKey
GH Research PLC Revenue Breakdown – NASDAQ:GHRS - TradingView
TradingKey - TradingKey
GH Research PLC (GHRS) Balance Sheet - TradingKey
GH Research PLC (GHRS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GHRS: GH Research PLC Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening - marketscreener.com
GH Research PLC (1KA.DU) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Why is GH Research stock trading higher on Thursday? - MSN
Price-Driven Insight from (GHRS) for Rule-Based Strategy - Stock Traders Daily
Samsara Stock And 2 Founder Led Software Picks With Real Revenue Growth - Sahm
Eli Lilly Drops $3.8 Billion on AtaiBeckley, Sending Psychedelic Stocks Soaring - finance.biggo.com
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time - Finansavisen
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer - Sahm
GHR Research PLC stock hits 52-week high at $30.20 - Investing.com
GHR Research PLC stock hits 52-week high at $30.20 By Investing.com - Investing.com South Africa
GH Research : GHRS - 24/7 Wall St.
Why Is GH Research Stock Trading Higher on Thursday? - Benzinga
Why is GH Research stock surging today? By Investing.com - Investing.com Nigeria
GH Research PLC (GHRS:UW): Stock Price, Quote and News - BNN Bloomberg
Eli Lilly Enters Psychedelic Drug Race With Up to $3.8 Billion AtaiBeckley Deal - finance.biggo.com
Why Psychedelic stocks are surging today - Yahoo Finance UK
GH Research (GHRS) In Focus As FDA Psychedelic Shift Raises The Question Of Value - Sahm
GH Research gains on optimism surrounding potential Eli Lilly-Atai deal (GHRS) - Yahoo Finance
Why is GH Research stock surging today? - Investing.com
GH Research stock jumps on Eli Lilly-Atai acquisition talks By Investing.com - Investing.com Nigeria
GH Research Surges 3.08% as Bullish Momentum Builds Above Key SupportCollar Trade - dars.gov.et
GH Research (GHRS) Declines Over 4% as Stock Tests Key Support LevelsGamma Squeeze - dars.gov.et
A3CUAZ Forecast — Price Target — Prediction for 2027 - TradingView
GH Research (GHRS) price target increased by 18.94% to 40.04 - MSN
GH Research (GHRS) Gains Ground: Bouncing Toward Key Resistance at $28.23Resistance Breakout Stocks - dars.gov.et
Price to sales forward of GH Research PLC – NASDAQ:GHRS - TradingView
Price to book forward of GH Research PLC – NASDAQ:GHRS - TradingView
GHRSGH Research PLC Options - Finviz
GH RESEARCH PLC (GHRS) Stock Chart - ChartMill
AtaiBeckley Stock Outlook Depends on Key Pipeline Catalysts in 2026 - TradingView
Is AtaiBeckley Stock Worth Buying After Its Stronger Rally in 2026? - TradingView
GH Research Plc Actuals & Estimates (FWB:1KA) - TradingView
Pre-Market Movement | GH Research Shares Surge to 52-Week High - 富途牛牛
GHRS Forecast — Price Target — Prediction for 2027 - TradingView
GHRS Stock Price and Chart — NASDAQ:GHRS - TradingView
(GHRS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Gh Research Plc Azioni (GHRS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):